Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 1;31(42):4867-73.
doi: 10.1016/j.vaccine.2013.07.051. Epub 2013 Aug 17.

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

Ainhoa Arbues  1 , Juan I Aguilo, Jesus Gonzalo-Asensio, Dessislava Marinova, Santiago Uranga, Eugenia Puentes, Conchita Fernandez, Alberto Parra, Pere Joan Cardona, Cristina Vilaplana, Vicente Ausina, Ann Williams, Simon Clark, Wladimir Malaga, Christophe Guilhot, Brigitte Gicquel, Carlos Martin
Affiliations

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

Ainhoa Arbues et al. Vaccine. .

Abstract

The development of a new tuberculosis vaccine is an urgent need due to the failure of the current vaccine, BCG, to protect against the respiratory form of the disease. MTBVAC is an attenuated Mycobacterium tuberculosis vaccine candidate genetically engineered to fulfil the Geneva consensus requirements to enter human clinical trials. We selected a M. tuberculosis clinical isolate to generate two independent deletions without antibiotic-resistance markers in the genes phoP, coding for a transcription factor key for the regulation of M. tuberculosis virulence, and fadD26, essential for the synthesis of the complex lipids phthiocerol dimycocerosates (DIM), one of the major mycobacterial virulence factors. The resultant strain MTBVAC exhibits safety and biodistribution profiles similar to BCG and confers superior protection in preclinical studies. These features have enabled MTBVAC to be the first live attenuated M. tuberculosis vaccine to enter clinical evaluation.

Keywords: BCG; Live attenuated vaccines; Tuberculosis vaccines.

PubMed Disclaimer

Publication types

MeSH terms